| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 11-07-2025 | 09-30-2025 | 10-Q | |
| 2 | 08-08-2025 | 06-30-2025 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $28 to ...
Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperform and raises the price ta...
Needham analyst Ryan MacDonald maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $26 to $28.
Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its p...
Omada Health (NASDAQ:OMDA) raises FY2025 sales outlook from $235.000 million-$241.000 million to $251.500 million-$254.500 mill...
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.13) ...
Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWee...
